Bio Equity 2019, the most important biopharmaceutical investor conference in Europe. Organized by BioCentury and EBD Group is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. SATT AxLR will be present.